Bio-AMD, Inc. (BIAD) shares gain 16% on Friday’s trading session within 9fold 10day average volume.
With a tiny market capitalization below $4M and two products ready for the commercialization, BIAD deserves to be added to your watch list. Keep in mind that the Company’s current focus is on securing commercial agreements with major distributors and / or manufacturers for its hand held medical device technologies:
Digital Strip Reader (DSR)
DSR is the universal digital strip reader capable of reading a variety of lateral flow strips to detect differing conditions based on a unique triple optical sensor arrangement. DSR offers an improved, simplified and cost effective disposable reader, featuring:
- New technology and new IP (patents filed)
- Unique interlocked cartridge cap
- Unique Quad Solar Cell light sensor array
- Clear digital LCD output to minimize errors
- Environmentally friendly – No batteries or chemicals (fully disposable)
- High sensitivity (semi-quantitative measurement)
- Tolerance free system
- Low manufacturing cost (higher profit margin)
- Ability to read any lateral flow strip including those using colour change
- Easy to use
Blood Coagulation Monitor (COAG)
COAG is a new, patent pending, hand-held meter device using combined magnetic/optical detection sensors, with a unique for micro-fluidic strip using very low blood volume, featuring:
- Lab accuracy to give patient day to day control of anti-coagulant intake
- State of the art digital electronics and embedded software
- Unique blood detection design (blood and plasma)
- Very low volume whole blood sample required (“finger-stick”)
- Fast response test result
- Temperature control with direct strip measurement
- External power supply and battery
- USB connection for data output
- Internal memory
- Easy to use
Bio-Alternative Medical Devices Ltd
Daresbury Science & Innovation Campus
Daresbury Innovation Centre
Keckwick Lane
Daresbury
Cheshire
WA4 4FS United Kingdom
Tel: +44 (0) 1925 606 471
Fax: +44 (0) 1925 606 475
Bio-AMD is in various stages of development of fully patented technology platforms that can be adapted to provide semi-quantitative and quantitative measurement in PoC devices, using both existing lateral flow and nano/micro-fluidic strips to detect a wide range of various medical conditions.